Skip to main content
Top
Published in: Diabetology & Metabolic Syndrome 1/2017

Open Access 01-12-2017 | Research

Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study

Authors: Luciana Bahia, Rosane Kupfer, Denise Momesso, Debora A. P. Cabral, Balduino Tschiedel, Marcia Puñales, Suzana Lavigne, Cristina F. S. Façanha, Adriana C. Forti, Angela D. N. Mendes, Bernardo R. Tura

Published in: Diabetology & Metabolic Syndrome | Issue 1/2017

Login to get access

Abstract

Background

Hypoglycemia is a critical and limiting factor of a good metabolic control and can adversely affect the quality of life of diabetic patients. The aim of the study was to evaluate the health-related quality of life and calculate utilities values associated with hypoglycemia in patients with type 1 diabetes mellitus (T1DM).

Methods

A multicenter, cross-sectional and observational study with T1DM patients from reference centers of the Brazilian public health system was conducted in three cities. Demographic and clinical data were collected, besides details on the frequency and severity of hypoglycemia. Health-related quality of life was assessed using EQ-5D instrument and utility values generated.

Results

221 patients (107 women, 114 men), aged 29.8 ± 11.6 and disease duration of 14.2 ± 9.1 years were included. Most patients (n = 214, 96.8%) reported at least one symptomatic hypoglycemia in the last three months, 68% (n = 150) reported nocturnal episodes and 34.8% (n = 77) reported severe episodes. High frequency (daily or weekly) was observed in 38.6 and 26% of those reporting nocturnal or severe hypoglycemia, respectively. The median visual analog scale was 70 [60–85] for all patients, with differences between those with and without severe hypoglycemia (70 [60–80] vs 80 [61–90]; p = 0.006) and those with high and low frequency (62.5 [50–72.25] vs 70 [60–80]; p = 0.007). The median utility values was 0.801 [0.756–1.000] for all patients, with difference between those with high and low frequency of severe episodes (0.737 [0.628–1.000] vs 0.801 [0.756–1.000]; p = 0.02).

Conclusions

This study shows the high frequency of hypoglycemia in a sample of T1DM patients treated in three reference centers of the Brazilian public health system and the impact of severe episodes on health-related quality of life. Utility values were generated and can be used in economic analysis for treatments that could decrease hypoglycemia and consequently improve quality of life.
Literature
3.
go back to reference Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005;21:1477–83.CrossRefPubMed Davis RE, Morrissey M, Peters JR, et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005;21:1477–83.CrossRefPubMed
4.
go back to reference Campolina AG, Ciconelli RM. Qualidade de vida e medidas de utilidade: parâmetros clínicos para as tomadas de decisão em saúde. Revista Panamericana de Saúde Pública. 2006;19(2):128–36.CrossRef Campolina AG, Ciconelli RM. Qualidade de vida e medidas de utilidade: parâmetros clínicos para as tomadas de decisão em saúde. Revista Panamericana de Saúde Pública. 2006;19(2):128–36.CrossRef
5.
go back to reference Drummond MF, Schulpher M. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005. Drummond MF, Schulpher M. Methods for the economic evaluation of health care programmes. 3rd ed. Oxford: Oxford University Press; 2005.
8.
go back to reference Braga de Souza ACC, Felicio JS, Koury CC, et al. Health-related quality of life in people with type 1 diabetes mellitus: data from the Brazilian Type 1 Diabetes Study Group. Health Q Life Outcomes. 2015;13:204.CrossRef Braga de Souza ACC, Felicio JS, Koury CC, et al. Health-related quality of life in people with type 1 diabetes mellitus: data from the Brazilian Type 1 Diabetes Study Group. Health Q Life Outcomes. 2015;13:204.CrossRef
9.
go back to reference Marrett E, Radican L, Davies MJ, Zhang Q. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: a survey study. BMC Res Notes. 2011;21(4):251. doi:10.1186/1756-0500-4-251.CrossRef Marrett E, Radican L, Davies MJ, Zhang Q. Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: a survey study. BMC Res Notes. 2011;21(4):251. doi:10.​1186/​1756-0500-4-251.CrossRef
10.
go back to reference Flores NM, Gupta S, Goren A, et al. Recent hypoglycemia episodes are associated with poorer quality of life, healthcare resource use, and work impairment among patients with type II diabetes in Brazil. Value Health. 2015;18(7):A865. doi:10.1016/j.jval.2015.09.515. Flores NM, Gupta S, Goren A, et al. Recent hypoglycemia episodes are associated with poorer quality of life, healthcare resource use, and work impairment among patients with type II diabetes in Brazil. Value Health. 2015;18(7):A865. doi:10.​1016/​j.​jval.​2015.​09.​515.
13.
go back to reference Lung TWC, Hayes AJ, Hayen A. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res. 2011;20:1669–78. doi:10.1007/s11136-011-9902-y.CrossRefPubMed Lung TWC, Hayes AJ, Hayen A. A meta-analysis of health state valuations for people with diabetes: explaining the variation across methods and implications for economic evaluation. Qual Life Res. 2011;20:1669–78. doi:10.​1007/​s11136-011-9902-y.CrossRefPubMed
Metadata
Title
Health-related quality of life and utility values associated to hypoglycemia in patients with type 1 diabetes mellitus treated in the Brazilian Public Health System: a multicenter study
Authors
Luciana Bahia
Rosane Kupfer
Denise Momesso
Debora A. P. Cabral
Balduino Tschiedel
Marcia Puñales
Suzana Lavigne
Cristina F. S. Façanha
Adriana C. Forti
Angela D. N. Mendes
Bernardo R. Tura
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Diabetology & Metabolic Syndrome / Issue 1/2017
Electronic ISSN: 1758-5996
DOI
https://doi.org/10.1186/s13098-017-0206-4

Other articles of this Issue 1/2017

Diabetology & Metabolic Syndrome 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.